Kang Mo Kim

31PUBLICATIONS
101CO-AUTHORS
Gastroenterology and hepatologyPredictive and prognostic markersMajor global burdens of diseaseHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|May 19, 2026
Standard-Dose Ursodeoxycholic Acid Improves Biochemical Liver Function and Fibrosis in Chronic Liver Disease: Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

|Dec 03, 2025
Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter Study.

Mira Kang, Won Chul Cha, Dong Hyun Sinn

|May 15, 2025
15-Year Trends in Hepatocellular Carcinoma: Epidemiology, Treatment, and Outcomes from a Hospital-Based Registry.

Songgyung Kim, Jina Park, Won-Mook Choi

|Mar 17, 2025
Association Between Viral Replication Activity and Postoperative Recurrence of HBV-Related Hepatocellular Carcinoma.

Subin Heo, Jiwon Yang, Jeayeon Park

|Feb 24, 2025
Synergistic Effects of Transarterial Chemoembolization and Lenvatinib on HIF-1α Ubiquitination and Prognosis Improvement in Hepatocellular Carcinoma.

Sung Won Chung, Jin Sun Kim, Won-Mook Choi

|Jan 28, 2025
Risk of Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab Treatment for Hepatocellular Carcinoma.

Kanghee Park, Hye Won Lee, Euichang Kim

Pageof 6

Frequent Collaborators

17 joint publications

Han Chu Lee

17 joint publications

Ju Hyun Shim

14 joint publications

Jonggi Choi

14 joint publications

Young-Suk Lim